Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
18.65
-0.46 (-2.41%)
Jul 9, 2026, 2:00 PM EDT - Market open
Apollomics Market Cap
Apollomics has a market cap or net worth of $40.96 million as of July 9, 2026. Its market cap has increased by 597.09% in one year.
Market Cap
40.96M
Enterprise Value
39.33M
1-Year Change
597.09%
Ranking
Category
Stock Price
$18.65
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $40.96M, a decrease of -68.40%. That is a compound annual growth rate of -22.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 40.96M | 2.08% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veru Inc. | 45.10M |
| INmune Bio | 44.26M |
| PDS Biotechnology | 43.77M |
| Eloxx Pharmaceuticals | 43.19M |
| Aligos Therapeutics | 42.95M |
| Lantern Pharma | 42.74M |
| ABVC BioPharma | 41.19M |
| RenovoRx | 40.86M |